Lead Biologics for Hormone Restoration

About JangoBio

JangoBio is a private, pre-clinical biotech advancing a novel approach to treating age-related decline by addressing hypogonadism—the loss of sex hormone-producing cells. The company is developing hormone-producing organoids derived from stem cells to rebalance the reproductive axis, with initial applications in companion animals (JangoPet) to generate data and revenue for future human trials. Its business model combines early revenue from service-based subsidiaries (JangoCell, JangoDx) with a long-term focus on developing allogeneic cell therapies for human age-related diseases.

Therapeutic Areas